This study aimed to characterize the autochthonous lactic acid bacteria (LAB) established in Traditional Mountain (TM) cheese, and to select strains with technological or health-promoting properties for cheese production. The results showed a high biodiversity of wild LAB within TM-cheese and the presence of few strains with bioactive properties. The two best technological performing strains (a Lactococcus lactis subsp. lactis and a Streptococcus thermophilus) were tested as starter cultures in experimental TM-cheese production. They did not reduce the traditional high biodiversity of TM-cheese, neither standardized its sensory attributes, and suppressed the incidence of the pathogen Sc. gallolyticus. Furthermore, a Lb. brevis strain showed in vitro a high production of GABA and was tested as probiotic strain in two animal studies. In the first study, it survived during transit through the mouse gastro-intestinal tract; in the second study its therapeutic efficiency was assessed for treating induced metabolic obesity and type 2 diabetes mellitus (T2DM) in mice.
Carafa, I.; Clementi, F.; Stanton, C.; Tuohy, K.M.; Franciosi, E. (2017). Characterization and health-promoting properties of traditional mountain cheese microbiota. In: 12th Iinternational meeting on mountain cheese, Padova, Italy, 20-22 June 2017. Padova: Padova University Press: 47-50. ISBN: 9788869380594. handle: http://hdl.handle.net/10449/43303
Characterization and health-promoting properties of traditional mountain cheese microbiota
Carafa, Ilaria
;Tuohy, Kieran Michael;Franciosi, Elena
2017-01-01
Abstract
This study aimed to characterize the autochthonous lactic acid bacteria (LAB) established in Traditional Mountain (TM) cheese, and to select strains with technological or health-promoting properties for cheese production. The results showed a high biodiversity of wild LAB within TM-cheese and the presence of few strains with bioactive properties. The two best technological performing strains (a Lactococcus lactis subsp. lactis and a Streptococcus thermophilus) were tested as starter cultures in experimental TM-cheese production. They did not reduce the traditional high biodiversity of TM-cheese, neither standardized its sensory attributes, and suppressed the incidence of the pathogen Sc. gallolyticus. Furthermore, a Lb. brevis strain showed in vitro a high production of GABA and was tested as probiotic strain in two animal studies. In the first study, it survived during transit through the mouse gastro-intestinal tract; in the second study its therapeutic efficiency was assessed for treating induced metabolic obesity and type 2 diabetes mellitus (T2DM) in mice.File | Dimensione | Formato | |
---|---|---|---|
2017 Carafa_Padova.pdf
solo utenti autorizzati
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
3.96 MB
Formato
Adobe PDF
|
3.96 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.